Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China

Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China

With one-fifth of the world’s total population, China’s prevention and control of cardiovascular disease (CVD) may affect the success of worldwide efforts to achieve sustainable CVD reduction. Understanding China’s current cardiovascular epidemic requires awareness of the economic development in the...

Full description

Bibliographic Details
Main Authors:	Wu, Y, Benjamin, E, MacMahon, S
Format:	Journal article
Published:	American Heart Association 2016

Similar Items

The Framingham Study, Diabetes Mellitus and Cardiovascular Disease: Turning Back the Clock
by: Kengne, A, et al.
Published: (2010)

Blood Pressure and Cardiovascular Disease: Tracing the Steps From Framingham
by: Turnbull, F, et al.
Published: (2010)

Fatal and Nonfatal Cardiovascular Disease and the Use of Therapies for Secondary Prevention in a Rural Region of India
by: Joshi, R, et al.
Published: (2009)

The rural Andhra Pradesh cardiovascular prevention study (RAPCAPS): A cluster randomized trial
by: Joshi, R, et al.
Published: (2012)

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease.
by: Collins, R, et al.
Published: (1994)

Stroke, coronary heart disease, cholesterol and blood pressure
by: Lewington, S, et al.
Published: (1997)

Antiplatelet therapy to prevent thrombosis after hip fracture. Rationale for a randomised trial.
by: MacMahon, S, et al.
Published: (1994)

Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration.
by: Lewington, S, et al.
Published: (1999)

Digital radiography of subtle pulmonary abnormalities : an roc study of the effect of pixel size on observer performance /
by: MacMahon, Heber

Climate change and the prevention of cardiovascular disease
by: Alan P. Jacobsen, et al.
Published: (2022-12-01)

Random errors in the measurement of 10 cardiovascular risk factors.
by: Whitlock, G, et al.
Published: (2001)

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.
by: Ninomiya, T, et al.
Published: (2013)

Blood pressure and coronary heart disease.
by: Collins, R, et al.
Published: (1990)

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies.
by: MacMahon, S, et al.
Published: (2001)

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.
by: Collins, R, et al.
Published: (2001)

Self-control as prevention of cardiovascular disease
by: Yu. A Manuylova
Published: (2016-06-01)

Pathways, technology and the patient—connected health through the lifecycle
by: Silvana Togneri MacMahon, et al.
Published: (2023-10-01)

The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture
by: Prentice, C, et al.
Published: (1999)

Changes in Cardiovascular Disease Burden in China after Release of the 2011 Chinese Guidelines for Cardiovascular Disease Prevention: A Bayesian Causal Impact Analysis
by: Zhao Yang, et al.
Published: (2023-10-01)

Blood pressure, cholesterol, and common causes ol death: A review
by: Lewington, S, et al.
Published: (1999)

Preface
by: Nasriah Morrison, et al.
Published: (2022-02-01)

Preface Spring 2022
by: Alyssa MacMahon, et al.
Published: (2022-05-01)

Reflections on the Algebra I Classroom Introduction
by: Alyssa MacMahon, et al.
Published: (2022-05-01)

Music Therapy and Medical Ethnomusicology: Distinctive and Connected
by: Jane Edwards, et al.
Published: (2015-11-01)

Community Detection for Correlation Matrices
by: Mel MacMahon, et al.
Published: (2015-04-01)

Blood-Pressure-Related Disease Is a Global Health Priority
by: MacMahon, S, et al.
Published: (2008)

Blood-pressure-related disease is a global health priority
by: MacMahon, S, et al.
Published: (2008)

Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials.
by: MacMahon, S, et al.
Published: (1988)

Prevention of cardiovascular diseases
by: Maria Stamova Vakrilova Becheva, et al.
Published: (2023-10-01)

Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare
by: Hyun, K, et al.
Published: (2017)

Recent developments in cardiovascular diseases control and prevention in India
by: Harshal T Pandve, et al.
Published: (2012-01-01)

Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors.
by: MacMahon, S, et al.
Published: (1997)

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
by: Neal, B, et al.
Published: (2000)

Primary Prevention of Cardiovascular Disease
by: Danny J. Eapen, et al.
Published: (2016-08-01)

Human Brain-Based Models Provide a Powerful Tool for the Advancement of Parkinson’s Disease Research and Therapeutic Development
by: Sarah F. McComish, et al.
Published: (2022-05-01)

Rapid Development of Targeting circRNAs in Cardiovascular Diseases
by: Chao Zhang, et al.
Published: (2020-09-01)

Modern opportunities for lifestyle changes and statin therapy in the prevention of cardiovascular diseases
by: M. G Bubnova
Published: (2017-09-01)

New guidelines and evidence for prevention and treatment of dyslipidemia and atherosclerotic cardiovascular disease in China
by: Da-Yi Hu
Published: (2017-06-01)

Implementing Fixed Dose Combination Medications for the Prevention and Control of Cardiovascular Diseases
by: Ruth Webster, et al.
Published: (2020-08-01)

Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study.
by: Miao Wang, et al.
Published: (2016-01-01)